Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Viking Therapeutics' dual GLP-1/GIP receptor agonists show potential in model of obesity

Nov. 8, 2021

Potent antiobesity effect seen with ZP-8396 in combination with semaglutide

Nov. 5, 2021

Chinese researchers present new glucose-lowering agents

Nov. 4, 2021

Structure-based optimization identifies potent galactokinase inhibitors

Nov. 3, 2021

Ndufv2 as a sex-specific genetic factor influencing mitochondrial functions

Nov. 2, 2021

Vertex Pharmaceuticals identifies new SERPINA1 polymerization inhibitors

Oct. 28, 2021

mLB-001 GeneRide vector restores hepatocyte function in MMA mice

Oct. 27, 2021

Novel split-intein-based gene therapy strategy to treat Wilson disease

Oct. 27, 2021

Vertex Pharmaceuticals discovers alpha-1-antitrypsin (Z-mutant) polymerization inhibitors

Oct. 27, 2021

VY-NPC101, a potential NPC1-based gene therapy strategy for Niemann-Pick disease type C

Oct. 27, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.